Bridgefront Capital, LLC Veracyte, Inc. Transaction History
Bridgefront Capital, LLC
- $312 Million
- Q3 2025
A detailed history of Bridgefront Capital, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Bridgefront Capital, LLC holds 6,785 shares of VCYT stock, worth $266,989. This represents 0.07% of its overall portfolio holdings.
Number of Shares
6,785Holding current value
$266,989% of portfolio
0.07%Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
325Shares Held
78.8MCall Options Held
94.6KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA8.5MShares$335 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$307 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI7.37MShares$290 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.47MShares$176 Million1.08% of portfolio
-
State Street Corp Boston, MA4.2MShares$165 Million0.01% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.82B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...